Malaysia handles the registration of combination products through the National Pharmaceutical Regulatory Agency (NPRA). Applicants must submit a single application, specifying the primary mode of action. The NPRA evaluates safety, efficacy, and quality, coordinating with relevant agencies to ensure compliance with pharmaceutical and medical device regulations for market approval.
